BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Integrated DNA Technologies Brings Innovation Nexus to San Francisco Bay Area

  May 5, 2025

   · 

  3 min read
• Press Releases

  Zimmer Biomet Announces First Quarter 2025 Financial Results

  May 5, 2025

   · 

  29 min read
• Press Releases

  Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

  May 5, 2025

   · 

  8 min read
• Press Releases

  INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th

  May 5, 2025

   · 

  4 min read
• Press Releases

  Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

  May 5, 2025

   · 

  22 min read
• Press Releases

  World Ovarian Cancer Coalition Leads Global Campaign to Raise Awareness of Ovarian Cancer

  May 5, 2025

   · 

  2 min read
• Press Releases

  Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025

  May 5, 2025

   · 

  1 min read
• Press Releases

  Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

  May 5, 2025

   · 

  8 min read
• Press Releases

  Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

  May 5, 2025

   · 

  5 min read
• Press Releases

  IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

  May 5, 2025

   · 

  2 min read